Creating successful ventures in health and life sciences.
A global, AI-First venture builder for Health and Life Sciences. We drive successful innovation through a systematic, AI-integrated approach.
advise, build, invest.
THE FRAMEWORK
Three pillars, one venture.
From the first hypothesis to the first round of capital, we stay with a venture across the full lifecycle. Three pillars, one proprietary framework, refined across every engagement.
01.
Advise.
Strategic advisory for founders, research institutions, and global health leaders. We work on commercialization strategy for research spin-offs, validation and prioritization frameworks, and investor readiness reviews ahead of fundraising.
Read more →02.
Build.
We co-build ventures alongside founders and partners. Every venture is structured AI-First from day zero, so it never accumulates the manual debt later-stage companies have to unwind. From spin-outs and corporate ventures to venture incubation, with equity participation alongside build mandates.
Read more →03.
Invest.
We connect founders with the right strategic investors and shape fundraising approaches. For investors, we provide due diligence support and curated dealflow in our focus areas across healthy aging and longevity. We do not run a fund.
Read more →THE METHOD
Providing proven frameworks to increase the success rate of tech ventures.
One readiness system with our own core frameworks to turn science into scalable companies. Six readiness dimensions across nine maturity levels, plus three proprietary canvases for application focus, commercial validation, and scientific evidence.
ADVISORS
Built with operators, not consultants.
Our advisor network combines C-level experience, scientific methodology and operator know-how from global leading companies. We bring the right advisor with a specific lens to ventures at specific readiness gates.
Dominik Moll
MedTech Entrepreneurs
Managing Partner MTE VC Fund and ex Management Board Johnson & Johnson. Two decades of executive leadership across J&J, Kimberly-Clark, and 3M. Healthcare angel investor and inventor of patented technologies.
Dr. Julia Bauer
Scientific Methodology
Head of Fraunhofer AHEAD Deep Tech Accelerator and tech-transfer researcher. Tech transfer scientist with deep experience in research translation, scientific validation pathways, and the methodology bridge from lab to product.
Benedikt von Braunmühl
Pharma/Biotech Innovation
Private Equity Operating Partner with a 30-year track record across international healthcare. Advises on M&A readiness, and the operating discipline that turns ventures into acquisition-ready companies.
NETWORK
Connected through Europe's leading entrepreneurship and innovation networks.
UnternehmerTUM. Sigma Squared Society. Senior leaders across MedTech and Pharma.
HOW WE WORK
AI-First, by design.
We have been working AI-First since the beginning of the AI boom. Every venture we co-build is structured AI-First from day zero, so it never accumulates the manual debt that older companies have to unwind.
01
Built AI-Native.
Process architectures, data flows, and decision logs designed to be AI-ready from day one. Every venture we co-build is structured this way from day zero.
02
Selective by Method.
Our AI-Fit Audit identifies where AI delivers ten times the value and where humans must stay in the loop. We do not deploy AI where it does not add measurable value.
03
Proven in Practice.
We have run AI-First inside many early-stage ventures across health and deep-tech, including our own operations. The operating model is tested, not theoretical.
WORKING WITH
Trusted by leading research institutions and global health leaders.
Max Planck Innovation
Fraunhofer AHEAD
Sartorius - Life Science Factory
Start2Group
EIT Health
Selected partners and clients we have advised or co-built ventures with
WORK WITH US
Let's build the future of health together.
Whether you're a founder, an investor, or a leader at a global company, we'd love to hear from you.